Whether you achieve a 20% weight reduction through bariatric surgery, strict dieting, or an AOM, the composition of that weight loss remains remarkably consistent
Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans
They made this hypothesis based on the autopsies of 21 diabetic patients
Claims about GLP-1 support rely on marketing language, placebo effects, or unproven ingredients rather than rigorous human trials
Shared decision-making between patients and clinicians should weigh cardiovascular benefits against cost, adverse effects, and individual treatment goals
Andrew Gostine Andrew Gostine, MD, MBA, is an accomplished healthcare professional, passionate about leveraging artificial intelligence in the clinical setting